PRMT5 Archives - Page 2 of 2

Solving SAM and MTA Measurement with Isotope Standards

by Jason Heaviland | Sep 21, 2025 | Uncategorized

Measuring the Unmeasurable The most critical metabolites in PRMT5 research are also the most challenging to measure accurately. S-adenosylmethionine (SAM) and methylthioadenosine (MTA) are essential for understanding PRMT5 biology, but their inherent chemical...

Why MTAP Alone Falls Short for PRMT5 Patient Selection

by Jason Heaviland | Sep 16, 2025 | Uncategorized

Why Genetic Biomarkers Aren’t Enough for PRMT5 Patient Selection The PRMT5 inhibitor field is facing a patient selection crisis that’s quietly undermining billion-dollar drug development programs. While genomic biomarkers promised to revolutionize...

The SDMA and ADMA Measurement Challenge

by Jason Heaviland | Sep 8, 2025 | Uncategorized

Why Accurate SDMA and ADMA Measurement Is Essential for PRMT5 Inhibitors The protein arginine methyltransferase (PRMT) field has a measurement problem that’s quietly undermining drug development programs across the industry. While symmetric dimethylarginine...

Research Area: PRMT5

Solving SAM and MTA Measurement with Isotope Standards

Why MTAP Alone Falls Short for PRMT5 Patient Selection

The SDMA and ADMA Measurement Challenge